José Oberholzer
Fundador en SIGILON THERAPEUTICS, INC. .
Perfil
José Oberholzer is the founder of Sigilon Therapeutics, Inc. He is currently the Director at Charles O Strickler Transplant Center since 2017.
Previously, he worked as a Professor at the University of Illinois and as the Head-Islet Transplant Program at the University of Geneva from 1998 to 2002.
Dr. Oberholzer has a graduate degree from Harvard University and an undergraduate degree from the University of Zurich Medical School.
Cargos activos de José Oberholzer
| Empresas | Cargo | Inicio |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Fundador | 14/05/2015 |
| Charles O Strickler Transplant Center | Director/Miembro de la Junta | 01/03/2017 |
Celltrans, Inc.
 Celltrans, Inc. Miscellaneous Commercial ServicesCommercial Services Celltrans, Inc. develops, manufactures, and commercializes cellular therapies and bioengineered technologies for the therapeutic treatment of diabetes and other endocrine disorders. The private company is based in Chicago, IL. The company was founded by José Oberholzer. | Fundador | - |
Antiguos cargos conocidos de José Oberholzer.
| Empresas | Cargo | Fin |
|---|---|---|
| University of Geneva | Corporate Officer/Principal | 01/01/2002 |
| University of Illinois | Corporate Officer/Principal | - |
Formación de José Oberholzer.
| Harvard University | Graduate Degree |
| University of Zurich Medical School | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SIGILON THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
| Charles O Strickler Transplant Center | |
Celltrans, Inc.
Celltrans, Inc. Miscellaneous Commercial ServicesCommercial Services Celltrans, Inc. develops, manufactures, and commercializes cellular therapies and bioengineered technologies for the therapeutic treatment of diabetes and other endocrine disorders. The private company is based in Chicago, IL. The company was founded by José Oberholzer. | Commercial Services |
- Bolsa de valores
- Insiders
- José Oberholzer
